← All trials
NCT03576963
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 22, 2018
- Primary completion
- Oct 22, 2020
- Completion date
- Oct 22, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 45
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Southern CaliforniaLead sponsor
- Astex Pharmaceuticals, Inc.Collaborator
- National Cancer Institute (NCI)Collaborator
- University of Southern CaliforniaOverall official - principal investigator
- University of Southern CaliforniaOfficial
- Bristol-Myers SquibbCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.